News

GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...
The American College of Rheumatology has updated its systemic lupus erythematosus treatment guidelines for the first time ...
Enpatoran, a TLR7/8 inhibitor, demonstrated clinically meaningful improvements in disease activity among patients with ...
Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...
Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...
Magnetic resonance imaging (MRI) findings such as inflammatory-type lesions and myelopathies are significantly associated with attribution of neuropsychiatric (NP) events to systemic lupus ...
A scoping review highlights key sex-related differences in SLE, showing more severe organ damage in men and distinct symptom and treatment patterns across sexes.
Treatment of systemic lupus erythematosus needs to fulfill a number of objectives Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences and ...
The US Food and Drug Administration (FDA) has approved GSK's 200 mg/ml autoinjector of Benlysta for individuals aged five ...
The FDA has approved a 200 mg/mL autoinjector of belimumab (Benlysta) for at-home subcutaneous use in children aged 5 years ...